In cell cycle regulation, Kato et al. (2012) and Rattan et al. (2011) showed that metformin can reduce the expression of cyclin D1, CDK4 and CDK6 in ovarian and gastric cancer cell lines and xenograft models. This evidence concerns the gene CDK4 and gastric cancer.